Intrasense

Equities

ALINS

FR0011179886

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 11:22:25 2024-05-10 EDT			5-day change	1st Jan Change
0.329 ^EUR	-0.90%		-8.10%	-8.61%

04-17	Intrasense: an innovative solution for cancer monitoring	CF
04-09	Guerbet: CE certificate for a platform	CF

Intrasense : annonce la nomination de Jérôme Thiebaud en tant que Chief Business Officer

April 24, 2024 at 02:12 am

Intrasense annonce la nomination de Jérôme Thiebaud en tant que Chief Business Officer

24 Apr 2024 08:00 CEST

Issuer

INTRASENSE

cp-nominationcbo.pdf

Source

INTRASENSE

Provider

Euronext

Company Name

INTRASENSE

ISIN

FR0011179886

Symbol

ALINS

Market

Euronext Growth

Attachments

Original Link
Permalink

Disclaimer

Intrasense SA published this content on 24 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 April 2024 06:11:37 UTC.

Latest news about Intrasense

Intrasense: an innovative solution for cancer monitoring	04-17	CF
Guerbet: CE certificate for a platform	04-09	CF
Intrasense: awarded CE certificate	04-09	CF
Invest Securities Raises Intrasense PT, Maintains Neutral Rating	03-22	MT
INTRASENSE : Invest Securities adjusts its target	03-22	CF
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
CAC40: gloomy end to the week, timid weekly gain (+0.7%)	02-09	CF
Intrasense: 2023 sales down on China	02-09	CF
Guerbet: sales growth of 4% by 2023	02-09	CF
Intrasense Partners with Software Company EDL for Myrian Distribution	23-10-19	MT
Intrasense S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-14	CI
Invest Securities Downgrades Intrasense to Neutral from Buy	23-08-04	MT
INTRASENSE : Invest Securities downgrades its recommendation	23-08-04	CF
Guerbet wins prostate cancer challenge	23-07-17	CF
Guerbet: agreement on AI for medical imaging	23-06-19	CF
Intrasense: joins Guerbet Group following successful takeover bid	23-06-12	CF
Guerbet: Intrasense joins the group	23-06-12	CF
Guerbet: holds 56.5% of Intrasense following reopening of its offer	23-06-09	CF
Guerbet SA completed the acquisition of 17.82% stake in Intrasense SA.	23-06-04	CI
Global markets live: Micron, Qantas, Zoom, Meta, BT Group...	23-05-23
Guerbet: takeover bid for Intrasense to resume on May 23	23-05-22	CF
Guerbet: successful takeover bid for Intrasense	23-05-22	CF
Guerbet: takeover bid opened for Intrasense shares	23-04-06	CF
Guerbet: AMF gives the green light to the takeover bid for Intrasense	23-04-05	CF
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI

Chart Intrasense

Duration

Period

More charts

Company Profile

Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1,200 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner...). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-10 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INTRASENSE	-8.61%	18.5M
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	-0.04%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology